Pharmacokinetics of intraperitoneal vancomycin in patients on automated peritoneal dialysis

Authors

Edwin Lam, Thomas Jefferson UniversityFollow
Yi Ting Kayla Lien, University of Florida
Valvanera Vozmediano, University of Florida
Stephan Schmidt, University of Florida
Walter K. Kraft, Thomas Jefferson UniversityFollow
Jingjing Zhang, Thomas Jefferson UniversityFollow

Files

Description

Primary Objective

• Characterize the pharmacokinetics of vancomycin in plasma, dialysate, and urine following a single intraperitoneal dose

Secondary Objective

• Explore the safety, tolerability, and feasibility in administering vancomycin during the long dwell period in patients on APD

Publication Date

9-13-2019

Keywords

vancomycin, automated peritoneal dialysis, peritonitis, pharmacokinetics

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Comments

Presented at the 2019 American College of Clinical Pharmacology (AACP) Annual Meeting

Recommended Citation

Lam, Edwin; Lien, Yi Ting Kayla; Vozmediano, Valvanera; Schmidt, Stephan; Kraft, Walter K.; and Zhang, Jingjing, "Pharmacokinetics of intraperitoneal vancomycin in patients on automated peritoneal dialysis" (2019). Department of Pharmacology and Experimental Therapeutics Posters. 7.
https://jdc.jefferson.edu/petposters/7